| Title: | Central Adiposity Increases Risk of Kidney Stone Disease through Effects on Serum Calcium Concentrations |
| Journal: | Journal of the American Society of Nephrology |
| Published: | 3 Oct 2023 |
| Pubmed: | https://pubmed.ncbi.nlm.nih.gov/37787550/ |
| DOI: | https://doi.org/10.1681/asn.0000000000000238 |
| URL: | https://journals.lww.com/jasn/abstract/9900/central_adiposity_increases_risk_of_kidney_stone.190.aspx |
| Citations: | 5 (5 in last 2 years) as of 8 Aug 2024 |
Publication 9431
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
Abstract
SIGNIFICANCE STATEMENT: Kidney stone disease is a common disorder with poorly understood pathophysiology. Observational and genetic studies indicate that adiposity is associated with an increased risk of kidney stone disease. However, the relative contribution of general and central adipose depots and the mechanisms by which effects of adiposity on kidney stone disease are mediated have not been defined. Using conventional and genetic epidemiological techniques, we demonstrate that general and central adiposity are independently associated with kidney stone disease. In addition, one mechanism by which central adiposity increases risk of kidney stone disease is by increasing serum calcium concentration. Therapies targeting adipose depots may affect calcium homeostasis and help to prevent kidney stone disease.</p>
BACKGROUND: Kidney stone disease affects approximately 10% of individuals in their lifetime and is frequently recurrent. The disease is linked to obesity, but the mechanisms mediating this association are uncertain.</p>
METHODS: Associations of adiposity and incident kidney stone disease were assessed in the UK Biobank over a mean of 11.6 years/person. Genome-wide association studies and Mendelian randomization (MR) analyses were undertaken in the UK Biobank, FinnGen, and in meta-analyzed cohorts to identify factors that affect kidney stone disease risk.</p>
RESULTS: Observational analyses on UK Biobank data demonstrated that increasing central and general adiposity is independently associated with incident kidney stone formation. Multivariable MR, using meta-analyzed UK Biobank and FinnGen data, established that risk of kidney stone disease increases by approximately 21% per one standard deviation increase in body mass index (BMI, a marker of general adiposity) independent of waist-to-hip ratio (WHR, a marker of central adiposity) and approximately 24% per one standard deviation increase of WHR independent of BMI. Genetic analyses indicate that higher WHR, but not higher BMI, increases risk of kidney stone disease by elevating adjusted serum calcium concentrations (β=0.12 mmol/L); WHR mediates 12%-15% of its effect on kidney stone risk in this way.</p>
CONCLUSIONS: Our study indicates that visceral adipose depots elevate serum calcium concentrations, resulting in increased risk of kidney stone disease. These findings highlight the importance of weight loss in individuals with recurrent kidney stones and suggest that therapies targeting adipose depots may affect calcium homeostasis and contribute to prevention of kidney stone disease.</p>
17 Authors
- Catherine E. Lovegrove
- Jelena Bešević
- Akira Wiberg
- Ben Lacey
- Thomas J. Littlejohns
- Naomi E. Allen
- Michelle Goldsworthy
- Jihye Kim
- Fadil M. Hannan
- Gary C. Curhan
- Ben W. Turney
- Mark I. McCarthy
- Anubha Mahajan
- Rajesh V. Thakker
- Michael V. Holmes
- Dominic Furniss
- Sarah A. Howles
1 Application
| Application ID | Title |
|---|---|
| 885 | Epidemiology of kidney stone disease |
Enabling scientific discoveries that improve human health